Current management of syncope: Treatment alternatives

被引:9
作者
Morillo C.A. [1 ]
Baranchuk A. [1 ]
机构
[1] Arrhythmia Service-Cardiology Div., McMaster University, HGH-McMaster Clinic, Hamilton, Ont. L8L 2X2
关键词
Disopyramide; Main Drug Interaction; Structural Heart Disease; Brugada Syndrome; Midodrine;
D O I
10.1007/s11936-004-0021-8
中图分类号
学科分类号
摘要
Syncope, defined as a transient loss of consciousness and postural tone with spontaneous recovery and no neurologic sequelae, is among one of the most common causes of consultation with a physician. The diagnostic workup is complex but can be simplified if focused on the underlying condition. Prognosis is highly dependent on the presence or absence of structural heart disease, primarily the presence of cardiomyopathy regardless of etiology, particularly if the left ventricutar (LV) function is less than 35%. The diagnostic approach to the patient with recurrent syncope and no structural heart disease is targeted to rule out neurally mediated causes. This approach usually includes a tilt table test (ie, head-up tilt), carotid sinus massage in patients older than 55 years, and an adenosine challenge test in patients who remain with unexplained syncope. Unexplained syncope in patients with reduced LV function (< 35%) may be potentially life-threatening. Infrequent causes of syncope should be sought in younger patients with a family history of sudden cardiac death. Channelopathies such as the long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia are among this variety. Therapy should address the potential mechanism of syncope. In neurally mediated causes, restoration of orthostatic tolerance, primarily by increasing volume during orthostatic stress, is recommended. Physiologic countermaneuvers and increase in salt and water intake are usually the initial therapy. With syncope in patients with an LV dysfunction (< 35%), an ICD is frequently recommended after ruling out common causes of syncope. Syncope in the elderly is usually multifactorial and therapy should include reassessment of multiple medications, which can promote neurally mediated syncope as well as searching for bradycardic causes. Empiric pacing may be used in this complex group of patients. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:371 / 383
页数:12
相关论文
共 62 条
[1]  
Kapoor W.N., Current evaluation and management of syncope, Circulation, 106, pp. 1606-1609, (2002)
[2]  
Brignole M., Alboni P., Benditt D., Et al., Guidelines on management (diagnosis and treatment) of syncope, Eur. Heart J., 22, pp. 1256-1306, (2001)
[3]  
Kaufmann H., Morillo C.A., Vascular pathologies controversies. Syncope in the elderly, (2004)
[4]  
Morillo C.A., Diagnostic evaluation and management of syncope, Heart Disease in Primary Care, pp. 266-275, (1999)
[5]  
Morillo C.A., Klein G.J., Gersh B.J., Can serial tilt testing be used to evaluate therapy in neurally mediated syncope?, Am. J. Cardiol., 77, pp. 521-523, (1996)
[6]  
Nino J., Villar J.C., Tahvanainen K.U., Et al., Vasovagal susceptibility to nitrate or isoproterenol head-up tilt, Am. J. Cardiol., 88, pp. 1326-1330, (2001)
[7]  
Morillo C.A., Eckberg D.L., Ellenbogen K.A., Et al., Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope, Circulation, 96, pp. 2509-2513, (1997)
[8]  
Morillo C.A., Ellenbogen K.A., Pava F.L., Pathophysiologic basis for vasodepressor syncope, Cardiol. Clin., 15, pp. 233-249, (1997)
[9]  
Ellenbogen A., Morillo C.A., Wood M.A., Et al., Neural monitoring of vasovagal syncope, Pacing Clin. Electrophysiol., 20, 3 PART 2, pp. 788-794, (1997)
[10]  
Rudas L., Crossman A.A., Morillo C.A., Et al., Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine, Am. J. Physiol., 276, 5 PART 2, (1999)